Project Grant R44DP006691
Award Date
9/30/24
Completion Date
9/29/26
Dollars Obligated
$2.5M
Funding Federal Agency
Office of the Director
Awarding Federal Agency
Office of Financial Resources
Awardee
Empowerx, Inc. (JJ17CL8MXNR8)
Federal Grant Program
93.283
Assistance Type
Project Grant
Place of Performance
United States
Similar Awards
This Project Grant award from the Centers for Disease Control and Prevention (CDC) Investigations and Technical Assistance program (CFDA 93.283) provides $399,148 to Inspire RX LLC in Ann Arbor, Michigan to develop a patient-worn negative pressure system to protect healthcare workers from the spread of highly transmissible infectious diseases. The award period runs from September 1, 2024 to August 31, 2025. The CDC program supports public health initiatives focused on controlling communicable...
This Cooperative Agreement award, titled "MODELING HIV, VIRAL HEPATITIS, STI, AND TB TO IMPROVE PUBLIC HEALTH - CAMP 3.0: THE COALITION FOR APPLIED MODELING FOR PREVENTION", is funded by the Centers for Disease Control and Prevention (CDC) under the HIV Prevention Activities Health Department Based program (CFDA 93.940). The $2,745,600 award will support Emory University and its sub-awardees, the University of Washington, Oregon Health & Science University, and Johns Hopkins...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $165,579 Cooperative Agreement to the County of Los Angeles Department of Public Health (DPH) under the CDC Investigations and Technical Assistance program (CFDA 93.283). The award, effective July 1, 2025 through June 30, 2030, will support a range of public health initiatives focused on controlling communicable diseases, chronic diseases, and other preventable health conditions in Los Angeles County. Through this Cooperative...
This $750,000 Project Grant award from the Centers for Disease Control and Prevention (CDC), under the CFDA 93.283 "Centers for Disease Control and Prevention Investigations and Technical Assistance" program, aims to improve outcomes for women through increased awareness of urinary incontinence. The 3-year award, which runs from September 30, 2024 to September 29, 2027, was granted to the National Association For Continence, a non-profit organization based in Lafayette, Colorado. The...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $21,608,922 Cooperative Agreement to the California Department of Public Health (CDPH) under the CDC Investigations and Technical Assistance program (CFDA 93.283). The award, effective July 1, 2025 through June 30, 2030, supports strengthening vaccine-preventable disease prevention and response across California. As the prime awardee, CDPH will deliver a range of public health services and interventions, including disease...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $99,253 Cooperative Agreement under the CDC Investigations and Technical Assistance program (CFDA 93.283) to the Maricopa County Department of Public Health in Arizona. The 5-year award, effective July 1, 2025, will support strengthening vaccine-preventable disease prevention and response efforts. The program funds public health initiatives focused on controlling communicable diseases, chronic diseases, and other preventable...
This Cooperative Agreement award, totaling $416,804.00, was provided by the Centers for Disease Control and Prevention (CDC) under the Investigations and Technical Assistance program (CFDA 93.283) to the City of New York, Department of Health and Mental Hygiene (Health Dept). The award aims to strengthen vaccine-preventable disease prevention and response efforts in New York City, with a project period from July 1, 2025 to June 30, 2030. The Health Dept, as the primary awardee, will utilize this...
This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Capacity Building Assistance (CBA) for High-Impact HIV Prevention program (CFDA 93.834) provides $15,351,606 to Cicatelli Associates, Inc. (CAI) to strengthen the capacity of health departments, community-based organizations, and the broader HIV prevention workforce. Specifically, CAI will deliver training and technical assistance services focused on promoting the adoption, implementation, and...
This federal Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Cooperative Agreements to Promote Adolescent Health through School-Based HIV/STD Prevention and School-Based Surveillance program (CFDA 93.079) provides $2,274,635.00 to ICF Macro Inc. to research and evaluate strategies aligned with the CDC's "What Works in Schools" approach. The five-year project aims to improve adolescent health and well-being through comprehensive...
This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the CDC Investigations and Technical Assistance program (CFDA 93.283) provides $1,142,400.00 to Health Research, Inc. over a 3-year period from September 1, 2024 to August 31, 2027. The funding will support state-level initiatives to advance oral health strategies and promotion. Health Research, Inc., a non-profit organization based in New York, will serve as the prime awardee and collaborate with...